This content is only available within our institutional offering.

07 Dec 2023
Cutting edge nanoparticle delivery system research

Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
Cutting edge nanoparticle delivery system research
N4 Pharma Plc (N4P:LON) | 0.5 0 0.0% | Mkt Cap: 7.24m
- Published:
07 Dec 2023 -
Author:
Barry Gibb -
Pages:
4 -
N4 Pharma has released an update on its ongoing in vitro double-loaded siRNA research work.